Research graph
References from Correlation and discriminatory performance of non-invasive serum fibrosis indices according to liver disease etiology using two-dimensional shear wave elastography as reference. Local targets link to admitted publications; unresolved targets remain external evidence.
Global burden of liver disease: 2023 update
10.1016/j.jhep.2023.03.017 · 2023 · External reference
Diagnosis and quantitation of fibrosis
10.1053/j.gastro.2008.03.001 · 2008 · External reference
EASL Clinical Practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis –2021 update
10.1016/j.jhep.2021.05.025 · 2021 · External reference
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
10.1053/jhep.2003.50346 · 2003 · External reference
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
10.1002/hep.21178 · 2006 · External reference
Lagging M. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers
10.1080/00365520510015674 · 2005 · External reference
King’s score: an accurate marker of cirrhosis in chronic hepatitis C
10.1097/meg.0b013e32830dfcb3 · 2009 · External reference
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
10.1053/jhep.2002.36128 · 2002 · External reference
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers
10.1002/hep.21984 · 2008 · External reference
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
10.1053/j.gastro.2018.12.036 · 2019 · External reference
Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity
2024 · External reference
Serum biomarkers predictive of cirrhosis in alcoholic liver disease as an alternative to ARFI-SW elastography
2023 · External reference
Concordance between hepatic biopsy and the APRI index for the diagnosis of cirrhosis in patients with autoimmune liver disease
10.1016/j.gastrohep.2020.07.005 · 2021 · External reference
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: a diagnostic or screening tool?
10.1016/j.jfma.2021.07.013 · 2022 · External reference
Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®
10.1016/j.jhep.2014.04.044 · 2014 · External reference
Comparing FIB-4, VCTE, pSWE, 2D-SWE, and MRE thresholds and diagnostic accuracies for detecting hepatic fibrosis in patients with MASLD: a systematic review and meta-analysis
2025 · External reference
Comparison between shear wave elastography and serological findings for the evaluation of fibrosis in chronic liver disease
10.15557/jou.2021.0030 · 2021 · External reference
Staging liver fibrosis in patients with chronic hepatitis B using two-dimensional shear wave elastography based on histopathological findings: a prospective multicenter study
10.21037/qims-22-831 · 2023 · External reference
Performance of 2D-shear wave elastography in autoimmune hepatitis–primary biliary cholangitis overlap syndrome
10.1007/s00261-023-03840-1 · 2023 · External reference
Accuracy of FibroScan, FIB-4, and NAFLD fibrosis score in predicting biopsy-defined fibrosis and steatosis in MASLD
10.1097/md.0000000000042016 · 2025 · External reference
The gamma-glutamyl transpeptidase to platelet ratio predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa
10.1136/gutjnl-2015-309260 · 2016 · External reference
Validity and clinical utility of the aspartate aminotransferase–alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus–related chronic liver disease
10.1001/archinte.163.2.218 · 2003 · External reference
METAVIR and CLINIVIR Cooperative Study Groups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus
10.1046/j.1365-2893.1997.00141.x · 1997 · External reference
FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis
2009 · External reference
Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level
2006 · External reference
A comparison of four fibrosis indexes in chronic HCV: development of a new fibrosis–cirrhosis index (FCI)
10.1186/1471-230x-11-44 · 2011 · External reference
Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection
1997 · External reference
Mean platelet volume, red cell distribution width to platelet count ratio, globulin platelet index, and 16 other indirect noninvasive fibrosis scores: how much do routine blood tests tell about liver fibrosis in chronic hepatitis C?
10.1097/mcg.0000000000000489 · 2016 · External reference
Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B
10.1111/j.1440-1746.2010.06383.x · 2010 · External reference
Global burden of alcoholic liver diseases
10.1016/j.jhep.2013.03.007 · 2013 · External reference
Clinical aspects, pathophysiology and treatment
2025 · External reference
Unravelling the coagulation paradox in liver cirrhosis: challenges and insights
10.1080/17843286.2025.2469906 · 2024 · External reference
Gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease
10.1002/jcla.24596 · 2022 · External reference
Correlation between point shear wave elastography and liver function tests as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease
10.53350/pjmhs211571936 · 2021 · External reference
Comparative evaluation of APRI, FIB-4, HFS, and NFS: scoring tools for liver fibrosis in a Mexican population with MASLD
2024 · External reference
Significance of correlation of shear wave elastography with fibrosis-4 in a cohort of patients with diabetes and nonalcoholic fatty liver disease
2024 · External reference
Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population
10.1016/j.cgh.2021.12.034 · 2022 · External reference
Noninvasive indirect markers of liver fibrosis in alcoholics
10.1155/2019/3646975 · 2019 · External reference
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
10.1016/j.jhep.2018.11.025 · 2019 · External reference
MetALD: diagnosis and prognosis with non-invasive tests
10.1111/apt.70281 · 2025 · External reference
